StockData
Immuron Ltd logo

Immuron Ltd (IMRN) stock

IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 24, 2026Score 4/30
$0.87−0.03 (-3.20%)

Close on Nov 17, 2026Market cap $7.03MP/E –Yield –

Immuron operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2026 it was -A$3.26M. The highest annual figure on record is -A$1.80M in fiscal 2019.

Annual operating cash flow

PeriodPeriod endValueChange
FY2026Jun 30, 2026-A$3.26M–
FY2025Jun 30, 2025-A$6.14M–
FY2024Jun 30, 2024-A$5.88M–
FY2023Jun 30, 2023-A$2.60M–
FY2022Jun 30, 2022-A$3.15M–
FY2021Jun 30, 2021-A$4.08M–
FY2020Jun 30, 2020-A$3.15M–
FY2019Jun 30, 2019-A$1.80M–
FY2018Jun 30, 2018-A$3.50M–
FY2017Jun 30, 2017-A$6.94M–
FY2016Jun 30, 2016-A$5.16M–

More Immuron figures

See a number that looks wrong?